跳至主要内容
临床试验/NCT04092023
NCT04092023已完成不适用

Effects of a Self-care Management Programme for Type 2 Adult Diabetic Patients With Poor Glycemic Control in General Out-patients Clinics - a Randomized Control Trial

Chinese University of Hong Kong1 个研究点 分布在 1 个国家目标入组 200 人开始时间: 2018年10月2日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
200
试验地点
1
主要终点
Glycemic control

研究概览

简要总结

Type 2 diabetes becomes the most prevalence chronic disease worldwide. Most type 2 diabetes patient are under the care in public general out-patient clinic in Hong Kong. The chronic nature of diabetic and the complexity of its management, on top of medication, diabetic patients often require behaviour modification and self-care management support. Effective diabetes self-care management education with patient-centered care approach with patients' participation and engagement has been shown to improve the clinical outcome. But such application during doctors' consultation are minimal in view of time limitation. Primary Care Nurse (PCN) is the first contact and is easily accessible in GOPCs. With support and training, PCN could act as a case manager to deliver the coordinated care. Interact and engage type 2 diabetes patients in self-care management, and work with multidisciplinary team in providing patient-centered care in GOPC setting. As there is lack of evidence about adopting such approach in the investigator's local population. This study is to test the effectiveness of the PCN led self-care management program to improve patients' clinical outcomes.

详细描述

  1. Safety Assessment

There is no harmful effect from the intervention. 2. Statistics

(A) Sample Size Estimation With reference from previous study (Aanand et al. 2011), the sample size is calculated by assuming change the reduction of HbA1c is 0.59% (intervention group 8.05% (SD 1.40) versus control group 8.64% (SD 1.39). In order to have 80% power and 5% false positive error, a sample size of 88 is needed for each arm using the public domain sample size calculator (https://www2.ccrb.cuhk.edu.hk/stat/). After consideration of 10% attrition rate, 97 participants will be recruited in each arm.

(B) Data Analysis All statistical analyses will be performed using SPSS Windows 22.0 program. P-value less than 0.05 will be considered statistically significant. All treatment evaluations will be performed on the principle of intention-to-treat analysis of the difference in outcomes between groups at 6 months after baseline. Missing values will be imputed using last value carrying forward method. Repeated analysis will be done for per-protocol analysis. Demographics and baseline characteristics will be summarized using descriptive statistics. Continuous variable will be summarized as numbers of observed values, mean and standard deviation. Categorical variables will be described as frequency and percentage. Information collected on all outcomes will be first summarized using descriptive statistics at baseline and at 6 months as appropriate. Linear regression model will be used to test the effect of intervention on the outcomes between 2 groups. 3. Direct Access to Source Data and Documents

Apart from the outpatient number and Initials, no subject sensitive identifier will be contained in the completed questionnaires. All completed questionnaires will be kept in knocked administrative room in research site with limited access by investigators. All patient records in CMS will be accessed by investigators only by their own CMS login. 4. Quality Control and Quality Assurance

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Other
盲法
Single (Outcomes Assessor)

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Clinically diagnosed of type 2 diabetes
  • Poorly glycemic control with recent HbA1c ≧ 7.5%
  • Chinese participants who could speak Cantonese

排除标准

  • Unable to perform self-care management due to physical or mental limitation
  • Engage in another similar program
  • Life expectancy <1 year due to malignancies or other terminal illness

结局指标

主要结局

Glycemic control

时间窗: Assess change from Baseline HbA1c at 6 months

Blood test for HbA1c

次要结局

  • QOL: Audit of Diabetes Dependent Quality of Life (ADDQoL-19)(Assess change from Baseline HbA1c at 6 months)
  • Self-Efficacy: Diabetes Empowerment Scale - Short Form (C-DES-SF)(Assess change from Baseline HbA1c at 6 months)
  • Diabetes Knowledge(Assess change from Baseline HbA1c at 6 months)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Chan Ching Yee

Principal Investigator

Chinese University of Hong Kong

研究点 (1)

Loading locations...

相似试验